Search for: "Dow v. State"
Results 961 - 980
of 1,049
Sorted by Relevance
|
Sort by Date
4 Jun 2008, 3:28 am
BAC level), whereas HGN does not. 16 A very recent investigation17 found that only HGN was effective at distinguishing persons above or below a BAC of .04%, a standard sometimes applied to drivers of commercial vehicles and, in some states, to drivers younger than 21. [read post]
3 Jun 2020, 11:49 am
Allen v. [read post]
14 Feb 2009, 11:56 am
Part V identifies key unresolved issues in the state courts. [read post]
20 Sep 2009, 11:07 pm
Vita-Mix v. [read post]
6 May 2010, 4:12 pm
., Mean v. [read post]
1 Nov 2021, 11:14 am
Miss United States of America, LLC. [read post]
13 Jun 2007, 12:41 pm
Such a decision was the Eighth Circuit's ruling in Watson v. [read post]
28 Apr 2008, 6:06 am
Merrell Dow Pharmaceuticals, Inc. [read post]
9 Mar 2007, 8:48 am
When he took office, the Dow stood at 2753. [read post]
16 Nov 2016, 8:11 am
You may have heard the name of this case before, but in most states the admissibility of expert testimony is governed by a Supreme Court case from the 1990s, Daubert v. [read post]
11 Apr 2012, 1:10 pm
As the plaintiff in Freedman v. [read post]
9 Mar 2013, 8:48 am
” Daubert v. [read post]
19 Jun 2024, 5:47 am
Merrill Dow Pharmaceuticals (1993) 509 U.S. 579 , 113 S. [read post]
12 May 2022, 2:17 am
See generally Lili Levi, ‘The Problem of Trans-National Libel’ (2012) 60 American Journal of Comparative Law 507. [4] Dow Jones & Co Inc v Gutnick (2002) 210 CLR 575. [5] But see Michael Douglas, ‘Characterisation of Breach of Confidence as a Privacy Tort in Private International Law’ (2018) 41 UNSW Law Journal 490. [6] Art 4(1); see Andrew Dickinson, The [read post]
15 Dec 2014, 8:30 am
During his time as a teacher he has also argued a number of major cases in state and federal courts, most notably Daubert v. [read post]
24 Jun 2018, 9:01 pm
In Haas v. [read post]
13 Jan 2010, 10:48 pm
One of the cited cases is Abright v. [read post]
2 Nov 2018, 7:32 pm
Merrill Dow Pharmaceuticals, Inc., 874 F.2d 307, 311-12 (5th Cir. 1989) (“Fortunately, we do not have to resolve any of the above questions [as to bias and confounding], since the studies presented to us incorporate the possibility of these factors by the use of a confidence interval. [read post]
4 Jan 2011, 4:08 pm
Merrell Dow Pharm., Inc., 509 U.S. 589 (1993)). [read post]
19 Sep 2011, 9:36 am
V. [read post]
